Azelastine Hydrochloride And Fluticasone Propionate Spray, Metered
NDC Package 0480-2157-57
Package Information
Azelastine Hydrochloride And Fluticasone Propionate sprays is azelastine hydrochloride and fluticasone propionate nasal spray is indicated for the relief of symptoms of seasonal allergic rhinitis in adult and pediatric patients 6 years of age and older. This formulation utilizes a spray, metered delivery system. Marketed by Teva Pharmaceuticals, Inc., this product is identified by NDC 0480-2157 and is authorized under FDA application ANDA208436.
Identification & Billing
- RxCUI: 1797847 - azelastine HCl 137 MCG/ACTUAT / fluticasone propionate 50 MCG/ACTUAT Metered Dose Nasal Spray
- RxCUI: 1797847 - azelastine hydrochloride 0.137 MG/ACTUAT / fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0480 - Teva Pharmaceuticals, Inc.
- 0480-2157 - Azelastine Hydrochloride And Fluticasone Propionate
- 0480-2157-57 - 1 BOTTLE, SPRAY in 1 CARTON / 120 SPRAY, METERED in 1 BOTTLE, SPRAY
- 0480-2157 - Azelastine Hydrochloride And Fluticasone Propionate
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0480-2157-57 identifies a specific commercial package of 1 bottle, spray in 1 carton / 120 spray, metered in 1 bottle, spray of Azelastine Hydrochloride And Fluticasone Propionate, a human prescription drug labeled by Teva Pharmaceuticals, Inc.. This spray, metered is formulated for nasal use and contains azelastine hydrochloride; fluticasone propionate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Teva Pharmaceuticals, Inc. on September 08, 2025. The current certification is valid through December 31, 2026.
How is this Teva Pharmaceuticals, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00480215757. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.